Protein Fermentation Products

Where it helps?

• Identifies whether protein fermentation is producing undesirable aromatic metabolites, not only whether protein fermentation is occurring.
• Links tryptophan, tyrosine, and phenylalanine degradation to gut environment quality.
• Supports evaluation of strategies designed to reduce putrefaction, odor-related metabolites, and epithelial stress.
• Complements BCFA by showing metabolite quality and potential biological relevance downstream of protein fermentation.
• For feed additive companies, this analysis is especially useful for positioning products that reduce harmful fermentation by-products and improve gut health profiles.

How does it work?

We typically analyze feces or digesta (e.g., ileum/cecum/colon), depending on the biological question and study design.

• Feces: practical for routine monitoring and field applications.
• Digesta: provides more detailed insight into fermentation dynamics in controlled studies.

What do we measure?

This analysis focuses on aromatic and putrefactive metabolites generated during microbial degradation of tryptophan, tyrosine, and phenylalanine:

• Indole – produced from tryptophan metabolism; linked to microbial activity and gut barrier interactions.
• Skatole (3-methylindole) – associated with protein fermentation and off-odors; high levels indicate elevated hindgut protein degradation.
• Phenol – derived from tyrosine fermentation; associated with microbial imbalance and epithelial stress.
• 4-methylphenol (p-cresol) – a key marker of protein fermentation linked to gut irritation and systemic effects.
• 4-ethylphenol – associated with microbial degradation of aromatic amino acids; contributes to gut environment changes.

Interpretation context

• Elevated indoles, phenols, and cresols indicate a shift toward putrefactive aromatic amino acid metabolism.
• This analysis is most useful when the question is not only whether protein fermentation is increased, but whether it is producing metabolites with stronger gut health relevance.

Typical use cases

• Protein optimization strategies: evaluate impact of reduced crude protein or improved amino acid balance.
• Protease validation: verify reduced formation of undesirable metabolites.
• Weaning and stress periods: monitor shifts toward harmful fermentation patterns.
• Raw material comparison: assess differences in protein digestibility and downstream effects.
• Gut health challenges: link dysbiosis to toxic metabolite production.

Sample types

• Feces (routine monitoring, on-farm sampling)
• Digesta (ileum/cecum/colon) from controlled trials

We can recommend the best sampling approach based on your objective (diagnostic monitoring vs. R&D trial endpoints).